SUNPHARMA had a stellar week, delivering a 7.99% return, significantly outperforming its peers. The stock's volatility was moderate at 17.28%, but its Sharpe Ratio of 1.79 indicates that the returns were achieved with relatively low risk. In comparison, peers DRREDDY, DIVISLAB, and HINDUNILVR underperformed, with returns ranging from -0.89% to 5.64%. Overall, SUNPHARMA's strong performance and moderate volatility make it an attractive option for investors.

[Volatility: 17.28%]